Approximately 30% of the global population is affected by metabolic-associated fatty liver disease (MASLD), a condition that ...

Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer [ID6339] Draft guidance Technology appraisal guidance 2 June 2025 Metabolic Dysfunction-Associated ...

Bayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...

Julie Wood the owner of Sonocare of East Texas and Peakabootique stopped by East Texas Live on Friday to discuss fatty liver ...